AXSOME THERAPEUTICS, INC. Amortization of Debt Issuance Costs
AXSOME THERAPEUTICS, INC. (AXSM) reported Amortization of Debt Issuance Costs of $527.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- AXSOME THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- AXSOME THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2025-06-30 was $134.00K, a 62.78% decline year-over-year.
- AXSOME THERAPEUTICS, INC. amortization of debt issuance costs for the quarter ending 2025-03-31 was $393.00K, a 12.61% increase year-over-year.
- AXSOME THERAPEUTICS, INC. amortization of debt issuance costs for fiscal 2025 was $527.00K, a 64.27% decline from fiscal 2024.
- AXSOME THERAPEUTICS, INC. amortization of debt issuance costs for fiscal 2024 was $1.48M, a 23.22% increase from fiscal 2023.
- AXSOME THERAPEUTICS, INC. amortization of debt issuance costs for fiscal 2023 was $1.20M, a 79.19% increase from fiscal 2022.
- AXSOME THERAPEUTICS, INC. amortization of debt issuance costs for fiscal 2022 was $668.00K, a 20.58% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 3 month as first filed | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 6 month as first filed | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 9 month as first filed | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $134.00K derived: sum of 3 quarters · filed 2026-08-10 | $527.00K 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $134.00K derived: sum of 2 quarters · filed 2026-08-10 | $527.00K 10-Q · filed 2025-11-03 | $917.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $134.00K 10-Q · filed 2026-08-10 | $527.00K 10-Q · filed 2026-08-10 | $917.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.29M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $393.00K 10-Q · filed 2026-05-04 | $783.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.16M derived: sum of 3 quarters · filed 2026-05-04 | $1.52M derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $765.00K derived: sum of 2 quarters · filed 2026-02-23 | $1.13M derived: sum of 3 quarters · filed 2026-02-23 | $1.48M 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $375.00K 10-Q · filed 2025-11-03 | $735.00K derived: sum of 2 quarters · filed 2025-11-03 | $1.08M 10-Q · filed 2025-11-03 | $1.43M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | $360.00K 10-Q · filed 2025-08-04 | $709.00K 10-Q · filed 2025-08-04 | $1.05M derived: sum of 3 quarters · filed 2026-02-23 | $1.38M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | $349.00K 10-Q · filed 2025-05-05 | $691.00K derived: sum of 2 quarters · filed 2026-02-23 | $1.02M derived: sum of 3 quarters · filed 2026-02-23 | $1.30M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | $342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $675.00K derived: sum of 2 quarters · filed 2026-02-23 | $947.00K derived: sum of 3 quarters · filed 2026-02-23 | $1.20M 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | $333.00K 10-Q · filed 2024-11-12 | $605.00K derived: sum of 2 quarters · filed 2024-11-12 | $855.00K 10-Q · filed 2024-11-12 | $1.06M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $272.00K 10-Q · filed 2024-08-05 | $522.00K 10-Q · filed 2024-08-05 | $728.00K derived: sum of 3 quarters · filed 2025-02-18 | $932.00K derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $250.00K 10-Q · filed 2024-05-06 | $456.00K derived: sum of 2 quarters · filed 2025-02-18 | $660.00K derived: sum of 3 quarters · filed 2025-02-18 | $820.00K derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $410.00K derived: sum of 2 quarters · filed 2025-02-18 | $570.00K derived: sum of 3 quarters · filed 2025-02-18 | $668.00K 10-K · filed 2025-02-18 | $668.05K 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $204.00K 10-Q · filed 2023-11-06 | $203.66K 10-Q · filed 2022-11-07 | $364.00K derived: sum of 2 quarters · filed 2023-11-06 | $462.00K 10-Q · filed 2023-11-06 | $461.69K 10-Q · filed 2022-11-07 | $567.90K derived: sum of 4 quarters · filed 2024-02-23 | ||
| 2022-06-30 | $160.00K 10-Q · filed 2023-08-07 | $160.18K 10-Q · filed 2022-08-09 | $258.00K 10-Q · filed 2023-08-07 | $258.04K 10-Q · filed 2022-08-09 | $363.90K derived: sum of 3 quarters · filed 2024-02-23 | $519.13K derived: sum of 4 quarters · filed 2024-02-23 | ||
| 2022-03-31 | $98.00K 10-Q · filed 2023-05-09 | $97.86K 10-Q · filed 2022-05-02 | $203.90K derived: sum of 2 quarters · filed 2024-02-23 | $359.13K derived: sum of 3 quarters · filed 2024-02-23 | $508.41K derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2021-12-31 | $105.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $261.13K derived: sum of 2 quarters · filed 2024-02-23 | $410.41K derived: sum of 3 quarters · filed 2024-02-23 | $554.00K 10-K · filed 2024-02-23 | $554.49K 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $155.23K 10-Q · filed 2022-11-07 | $304.51K derived: sum of 2 quarters · filed 2022-11-07 | $448.10K 10-Q · filed 2022-11-07 | $592.32K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $149.28K 10-Q · filed 2022-08-09 | $292.87K 10-Q · filed 2022-08-09 | $437.09K derived: sum of 3 quarters · filed 2023-02-28 | $524.52K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $143.59K 10-Q · filed 2022-05-02 | $287.81K derived: sum of 2 quarters · filed 2023-02-28 | $375.24K derived: sum of 3 quarters · filed 2023-02-28 | $494.25K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $144.22K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $231.65K derived: sum of 2 quarters · filed 2023-02-28 | $350.66K derived: sum of 3 quarters · filed 2023-02-28 | $469.68K 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $87.42K 10-Q · filed 2021-11-08 | $206.44K derived: sum of 2 quarters · filed 2021-11-08 | $325.45K 10-Q · filed 2021-11-08 | $445.77K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $119.01K 10-Q · filed 2021-08-09 | $238.03K 10-Q · filed 2021-08-09 | $358.35K derived: sum of 3 quarters · filed 2022-03-01 | $478.67K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $119.01K 10-Q · filed 2021-05-10 | $239.34K derived: sum of 2 quarters · filed 2022-03-01 | $359.66K derived: sum of 3 quarters · filed 2022-03-01 | $485.92K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $120.32K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $240.64K derived: sum of 2 quarters · filed 2022-03-01 | $366.90K derived: sum of 3 quarters · filed 2022-03-01 | $436.57K 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $120.32K 10-Q · filed 2020-11-05 | $246.58K derived: sum of 2 quarters · filed 2020-11-05 | $316.25K 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $126.26K 10-Q · filed 2020-08-10 | $195.92K 10-Q · filed 2020-08-10 | ||||||
| 2018-12-31 | $266.67K 10-K · filed 2021-03-01 | |||||||
| 2017-12-31 | $346.98K 10-K · filed 2020-03-12 | |||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $2.23K derived: sum of 2 quarters · filed 2018-03-07 | $5.95K derived: sum of 3 quarters · filed 2018-03-07 | $7.76K 10-K · filed 2018-03-07 | ||||
| 2015-09-30 | $2.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $5.95K derived: sum of 2 quarters · filed 2016-11-14 | $7.76K 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $3.72K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-09 | $5.52K 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | $1.81K 10-Q/A · filed 2016-08-09 | |||||||
| 2014-12-31 | $143.81K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |